Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
Titel:
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
Auteur:
Sharman, Jeff P Egyed, Miklos Jurczak, Wojciech Skarbnik, Alan Pagel, John M Flinn, Ian W Kamdar, Manali Munir, Talha Walewska, Renata Corbett, Gillian Fogliatto, Laura Maria Herishanu, Yair Banerji, Versha Coutre, Steven Follows, George Walker, Patricia Karlsson, Karin Ghia, Paolo Janssens, Ann Cymbalista, Florence Woyach, Jennifer A Salles, Gilles Wierda, William G Izumi, Raquel Munugalavadla, Veerendra Patel, Priti Wang, Min Hui Wong, Sofia Byrd, John C